Literature DB >> 20112124

Serum levels of brain-derived neurotrophic factor in Sydenham's chorea.

Antônio Lúcio Teixeira1, Thales Lage Bretas, Arthur Kummer, Lívia Cunha Melo, Amanda Baraldi, Estefânia Harsányi, Francisco Cardoso, Elizabeth Ribeiro da Silva Camargos.   

Abstract

Sydenham's chorea (SC) is the neurologic manifestation of rheumatic fever. In addition to involuntary movements, SC patients show behavioral changes, such as hyperactivity, obsessions, and compulsions. Brain-derived neurotrophic factor (BDNF) is related to neuronal development and differentiation. Since BDNF serum levels are altered in a series of neuropsychiatric disorders, such as schizophrenia and Huntington's disease, we investigated the serum levels of BDNF in SC patients. Eighteen patients with acute SC, 4 with persistent SC and 27 control subjects were included in this study. BDNF was determined by ELISA. There was no significant difference between BDNF serum levels of control and acute SC groups (P = 0.12). Persistent SC patients presented decreased BDNF levels when compared to both control and acute SC groups (P < 0.001). Our results suggest that the persistence of symptoms in SC may be related to structural changes in the central nervous system as expressed by altered BDNF levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20112124     DOI: 10.1007/s10072-009-0209-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  22 in total

1.  Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients.

Authors:  Aitor Palomino; Ainara Vallejo-Illarramendi; Ana González-Pinto; Ana Aldama; Cristina González-Gómez; Fernando Mosquera; Gixane González-García; Carlos Matute
Journal:  Schizophr Res       Date:  2006-07-10       Impact factor: 4.939

Review 2.  Seminar on choreas.

Authors:  Francisco Cardoso; Klaus Seppi; Katherina J Mair; Gregor K Wenning; Werner Poewe
Journal:  Lancet Neurol       Date:  2006-07       Impact factor: 44.182

3.  Sydenham's chorea: magnetic resonance imaging of the basal ganglia.

Authors:  J N Giedd; J L Rapoport; M J Kruesi; C Parker; M B Schapiro; A J Allen; H L Leonard; D Kaysen; D P Dickstein; W L Marsh
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

Review 4.  Brain-derived neurotrophic factor.

Authors:  Devin K Binder; Helen E Scharfman
Journal:  Growth Factors       Date:  2004-09       Impact factor: 2.511

5.  UFMG Sydenham's chorea rating scale (USCRS): reliability and consistency.

Authors:  Antônio Lúcio Teixeira; Débora P Maia; Francisco Cardoso
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

6.  Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor.

Authors:  Zachary C Baquet; Jessica A Gorski; Kevin R Jones
Journal:  J Neurosci       Date:  2004-04-28       Impact factor: 6.167

7.  Blood levels of catecholamine metabolites and brain-derived neurotrophic factor in a case of Sydenham's chorea.

Authors:  Wakako Umene; Reiji Yoshimura; Hikaru Hori; Hideki Nakano; Atsuko Sugita; Masayuki Shimono; Kenchi Takano; Naoki Shiota; Yoshinori Tomoda; Yukunori Korogi; Jun Nakamura
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132

8.  Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea.

Authors:  Patrícia C Faustino; Maria Teresa R A Terreri; Antônio J da Rocha; Marcelo C Zappitelli; Henrique M Lederman; Maria Odete E Hilário
Journal:  Neuroradiology       Date:  2003-06-17       Impact factor: 2.804

9.  Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.

Authors:  Helton José Reis; Rodrigo Nicolato; Izabela Guimarães Barbosa; Paulo Henrique Teixeira do Prado; Marco Aurélio Romano-Silva; Antonio Lucio Teixeira
Journal:  Neurosci Lett       Date:  2008-05-13       Impact factor: 3.046

10.  Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.

Authors:  Ge Li; Elaine R Peskind; Steven P Millard; Peter Chi; Izabela Sokal; Chang-En Yu; Lynn M Bekris; Murray A Raskind; Douglas R Galasko; Thomas J Montine
Journal:  PLoS One       Date:  2009-05-01       Impact factor: 3.240

View more
  1 in total

1.  Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham's Chorea: A Multicenter Prospective Study.

Authors:  Alessandro Orsini; Thomas Foiadelli; Attilio Sica; Andrea Santangelo; Niccolò Carli; Alice Bonuccelli; Rita Consolini; Sofia D'Elios; Nicolò Loddo; Alberto Verrotti; Giuseppe Di Cara; Chiara Marra; Maria Califano; Anna Fetta; Marianna Fabi; Stefania Bergamoni; Aglaia Vignoli; Roberta Battini; Marta Mosca; Chiara Baldini; Nadia Assanta; Pietro Marchese; Gabriele Simonini; Edoardo Marrani; Francesca Felicia Operto; Grazia Maria Giovanna Pastorino; Salvatore Savasta; Giuseppe Santangelo; Virginia Pedrinelli; Gabriele Massimetti; Liliana Dell'Osso; Diego Peroni; Duccio Maria Cordelli; Martina Corsi; Claudia Carmassi
Journal:  Int J Environ Res Public Health       Date:  2022-08-25       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.